The DOI matches its Crossref record; 167 of the 170 references it cites were found in a registry or an index.
The role of interleukin-6 signaling in nervous tissue
Open accessAbstract
The cytokine interleukin-6 (IL-6) plays a critical role in the pathogenesis of inflammatory disorders and in the physiological homeostasis of neural tissue. Profound neuropathological changes, such as multiple sclerosis (MS), Parkinson's and Alzheimer's disease are associated with increased IL-6 expression in brain. Increased nocturnal concentrations of serum IL-6 are found in patients with impaired sleep whereas IL-6-deficient mice spend more time in rapid eye movement sleep associated with dreaming. IL-6 is crucial in the differentiation of oligodendrocytes, regeneration of peripheral nerves and acts as a neurotrophic factor. It exerts its cellular effects through two distinct pathways which include the anti-inflammatory pathway involving the membrane-bound IL-6 receptor (IL-6R) expressed on selective cells, including microglia, in a process known as classical signaling that is also critical for bacterial defense. In classical signaling binding of IL-6 to the membrane-bound IL-6R activates the β-receptor glycoprotein 130 (gp130) and subsequent down-stream signaling. The alternative, rather pro-inflammatory pathway, shown to mediate neurodegeneration in mice, termed trans-signaling, depends on a soluble form of the IL-6R that is capable of binding IL-6 to stimulate a response on distal cells that express gp130. A naturally occurring soluble form of gp130 (sgp130) has been identified that can specifically bind and neutralize the IL-6R/IL-6 complex. Thus, trans-signaling is blocked but classical signaling is completely unaffected. A modified, recombinant dimerized version of sgp130 (sgp130Fc) has successfully been used to block inflammatory processes in mice and may also be used in the clarification of IL-6 trans-signaling in neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies have reported that intracranial IL6 and IL6 signaling using non-canonical trans-signaling modalities impact behavior (Rothaug et al., 2016).”
From Origin and function of stress-induced IL-6 in murine models (2020) · cites this paper as Rothaug et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 1×
“inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1 (CT-1), neuropoietin and cardiotrophin-like cytokine factor-1 (also known as new neurotrophin 1 and B cell stimulatory factor-3) [24-28].”
BackgroundMuscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,896
Gauldie, J., Richards, C. D., Harnish, D. C., Lansdorp, P. M., & Baumann, H. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
Flagged first, then by citations
3 of the 170 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Marz, 1999, Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression, Glia, 26, 191, 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-# · DOI
Cited by
Sorted by citations
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
“[210] Rothaug M, Becker-Pauly C, Rose-John S.”
BackgroundInterleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Su, H., Lei, C., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00405 · Cited by 554
Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner
Willis, E. F., MacDonald, K. P. A., Nguyen, Q. H., Garrido, A. L., Gillespie, E. R., Harley, S. B. R., Bartlett, P. F., Schroder, W. A., Yates, A. G., Anthony, D. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.013 · Cited by 520
Post-stroke inflammation—target or tool for therapy?
Lambertsen, K. L., Finsen, B. R., & Clausen, B. H. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1930-z · Cited by 477
What does plasma CRP tell us about peripheral and central inflammation in depression?
Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0096-3 · Cited by 448
Physical Activity and Brain Health
Liegro, C. M. D., Schiera, G., Proia, P., & Liegro, I. D. (2019) · Genes · doi:10.3390/genes10090720 · Cited by 451
Shinozaki, Y., Shibata, K., Yoshida, K., Shigetomi, E., Gachet, C., Ikenaka, K., Tanaka, K. F., & Koizumi, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.047 · Cited by 356
The shedding protease ADAM17: Physiology and pathophysiology
Zunke, F., & Rose‐John, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.07.001 · Cited by 337
Origin and function of stress-induced IL-6 in murine models
Qing, H., Desrouleaux, R., Israni-Winger, K., Mineur, Y. S., Fogelman, N., Zhang, C., Rashed, S., Palm, N. W., Sinha, R., Picciotto, M. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.054 · Cited by 303
IL-6 signalling pathways and the development of type 2 diabetes
Akbari, M., & Hassan‐Zadeh, V. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0458-0 · Cited by 315
Role of IL-6 in the regulation of neuronal development, survival and function
Kummer, K. K., Zeidler, M., Kalpachidou, T., & Kress, M. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155582 · Cited by 281
Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis
Khaboushan, A. S., Yazdanpanah, N., & Rezaei, N. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02725-6 · Cited by 286
IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling
Timper, K., Denson, J. L., Steculorum, S. M., Heilinger, C., Engström-Ruud, L., Wunderlich, C. M., Rose-John, S., Wunderlich, F. T., & Brüning, J. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.043 · Cited by 233
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
Roohi, E., Jaafari, N., & Hashemian, F. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02100-7 · Cited by 256
Deep insight into cytokine storm: from pathogenesis to treatment
Nie, J., Zhou, L., Tian, W., Liu, X., Yang, L., Yang, X., Zhang, Y., Wei, S., Wang, D. W., & Wei, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02178-y · Cited by 251
Perry, B. I., Upthegrove, R., Kappelmann, N., Jones, P. B., Burgess, S., & Khandaker, G. M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.009 · Cited by 187
Interleukin-6 as a Multifunctional Regulator: Inflammation, Immune Response, and Fibrosis
Choy, E., & Rose-John, S. (2017) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000265 · Cited by 174
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development
Pegoretti, V., Swanson, K. A., Bethea, J. R., Probert, L., Eisel, U. L. M., & Fischer, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7191080 · Cited by 187
Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer’s disease
Sun, N., Akay, L. A., Murdock, M. H., Park, Y., Galiana-Melendez, F., Bubnys, A., Galani, K., Mathys, H., Jiang, X., Ng, A. P., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01334-3 · Cited by 186
Kim, T. D., Lee, S. L., & Yoon, S. J. (2020) · Antioxidants · doi:10.3390/antiox9020107 · Cited by 169
The soluble interleukin 6 receptor: advanced therapeutic options in inflammation
Rose‐John, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.782 · Cited by 169
Interleukin-6 signalling in health and disease
Rose‐John, S. (2020) · F1000Research · doi:10.12688/f1000research.26058.1 · Cited by 167
The Influence of Fluorine on the Disturbances of Homeostasis in the Central Nervous System
Dec, K., Łukomska, A., Maciejewska, D., Jakubczyk, K., Baranowska‐Bosiacka, I., Chlubek, D., Wąsik, A., & Gutowska, I. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0871-4 · Cited by 154
Mirabella, F., Desiato, G., Mancinelli, S., Fossati, G., Rasile, M., Morini, R., Markicevic, M., Grimm, C., Amegandjin, C. A., Termanini, A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.006 · Cited by 152
Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk
Scisciola, L., Fontanella, R. A., Surina, S., Cataldo, V., Paolisso, G., & Barbieri, M. (2021) · Life · doi:10.3390/life11020173 · Cited by 153
Hawkins, S., Crompton, L., Sood, A., Saunders, M., Boyle, N. T., Buckley, A. M., Minogue, A. M., McComish, S. F., Jiménez-Moreno, N., Llana, O. C., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0085-3 · Cited by 135
Neurobiological basis of stress resilience
Nestler, E. J., & Russo, S. J. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.001 · Cited by 148
“Hypothalamic Microinflammation” Paradigm in Aging and Metabolic Diseases
Cai, D., & Khor, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.021 · Cited by 138
Depression and Interleukin-6 Signaling: A Mendelian Randomization Study
Kelly, K. M., Smith, J. A., & Mezuk, B. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.019 · Cited by 117
Cytokine signaling in multiple sclerosis: Lost in translation
Göbel, K., Ruck, T., & Meuth, S. G. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518763094 · Cited by 122
Salas-Venegas, V., Flores-Torres, R. P., Rodríguez-Cortés, Y. M., Rodríguez-Retana, D., Carreto, R. J. R., Concepción-Carrillo, L. E., Pérez-Flores, L. J., Alarcón‐Aguilar, A., López‐Díazguerrero, N. E., Gómez‐González, B., et al. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.798995 · Cited by 126
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia
Saba, J., Couselo, F. L., Bruno, J., Carniglia, L., Durand, D., Lasaga, M., & Caruso, C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666211201094608 · Cited by 117
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 119
Muscle-to-Brain Signaling Via Myokines and Myometabolites
Rai, M., & Demontis, F. (2022) · Brain Plasticity · doi:10.3233/bpl-210133 · Cited by 126
Kreiner, F. F., Kraaijenhof, J. M., von Herrath, M., Hovingh, G. K., & von Scholten, B. J. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2045952 · Cited by 115
Microglia responses to interleukin‐6 and type I interferons in neuroinflammatory disease
West, P. K., Viengkhou, B., Campbell, I. L., & Hofer, M. J. (2019) · Glia · doi:10.1002/glia.23634 · Cited by 101
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Silva, N. M. L. E., Barros‐Aragão, F. G. Q., Felice, F. G. D., & Ferreira, S. T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109023 · Cited by 96
Mohammadi, S., Moosaie, F., & Aarabi, M. H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02094-y · Cited by 89
The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions
Kerkis, I., da Silva, Á. R. D. B. P., & Araldi, R. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1400533 · Cited by 94
How inflammation dictates diabetic peripheral neuropathy: An enlightening review
Cheng, Y., Chen, Y., Li, K., Liu, S., Pang, C., Gao, L., Xie, J., Wenjing, L. V., Yu, H., & Deng, B. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14477 · Cited by 107
The hormetic and hermetic role of IL-6
Forcina, L., Franceschi, C., & Musarò, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101697 · Cited by 85
Yang, G., Xu, X., Gao, W., Wang, X., Zhao, Y., & Xu, Y. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1700692 · Cited by 85
The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
Petralia, M. C., Mazzon, E., Fagone, P., Basile, M. S., Lenzo, V., Quattropani, M. C. A., Nuovo, S. D., Bendtzen, K., & Nicoletti, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102504 · Cited by 89
Habiyaremye, G., Morales, D. M., Morgan, C. D., McAllister, J. P., CreveCoeur, T. S., Han, R. H., Gabir, M., Baksh, B. S., Mercer, D., & Limbrick, D. D. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0083-0 · Cited by 83
Porcher, L., Bruckmeier, S., Burbano, S. D., Finnell, J. E., Gorny, N., Klett, J., Wood, S. K., & Kelly, M. P. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02252-6 · Cited by 83
What are the links between hypoxia and Alzheimer’s disease?
Lall, R., Mohammed, R., & Ojha, U. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s203103 · Cited by 81
Cancelliere, R., Tinno, A. D., Lellis, A. M. D., Contini, G., Micheli, L., & Signori, E. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114467 · Cited by 77
Visñuk, D. P., de Giori, G. S., LeBlanc, J. G., & de LeBlanc, A. D. M. (2020) · Nutrition · doi:10.1016/j.nut.2020.110995 · Cited by 76
The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives
Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 84
Neuroinflammation in psychiatric disorders: An introductory primer
Dunn, G. A., Loftis, J. M., & Sullivan, E. L. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172981 · Cited by 73
Anti-inflammatory role of GM1 and other gangliosides on microglia
Galleguillos, D., Wang, Q., Steinberg, N., Zaidi, A. K., Shrivastava, G., Dhami, K., Daskhan, G. C., Schmidt, E. N., Dworsky-Fried, Z., Giuliani, F., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02374-x · Cited by 74
Briguglio, M., Bona, A. R., Porta, M., Dell’Osso, B. M., Pregliasco, F. E., & Banfi, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00671 · Cited by 70
Defining the role of anti- and pro-inflammatory outcomes of Interleukin-6 in mental health.
García-Juárez, M. G., & Camacho-Morales, A. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.03.020 · Cited by 61
Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
Yang, S. (2019) · International Neurourology Journal · doi:10.5213/inj.1938184.092 · Cited by 72
Lolansen, S. D., Rostgaard, N., Barbuskaite, D., Capion, T., Olsen, M. H., Nørager, N. H., Vilhardt, F., Andreassen, S. N., Toft‐Bertelsen, T. L., Ye, F., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00360-w · Cited by 68
Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology
Riphagen, J. M., Ramakers, I. H. G. B., Freeze, W. M., Pagen, L. H. G., Hanseeuw, B. J., Verbeek, M. M., Verhey, F. R. J., & Jacobs, H. I. L. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.020 · Cited by 66
Gajtkó, A., Bakk, E., Hegedűs, K., Ducza, L., & Holló, K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.543331 · Cited by 70
DNA Methylation Profiles of Selected Pro-Inflammatory Cytokines in Alzheimer Disease
Nicolia, V., Cavallaro, R. A., López‐González, I., Maccarrone, M., Scarpa, S., Ferrer, I., & Fuso, A. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw099 · Cited by 65
Roberts, A. J., Khom, S., Bajo, M., Vlkolinský, R., Polis, I. Y., Cates‐Gatto, C., Roberto, M., & Gruol, D. L. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.185 · Cited by 67
Neuroprotective Metabolites of Hericium erinaceus Promote Neuro-Healthy Aging
Roda, E., Priori, E. C., Ratto, D., Luca, F. D., Iorio, C. D., Angelone, P., Locatelli, C., Desiderio, A., Goppa, L., Savino, E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126379 · Cited by 72
IL-6 and its role in IgA nephropathy development
Groza, Y., Jemelková, J., Kafkova, L. R., Malý, P., & Raška, M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.04.001 · Cited by 67
Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity
Toral-Ríos, D., Patiño‐López, G., Gómez‐Lira, G., Gutiérrez, R., Becerril-Pérez, F., Rosales-Córdova, A., León‐Contreras, J. C., Hernández‐Pando, R., León‐Rivera, I., Soto‐Cruz, I., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207458 · Cited by 63
Astrocytic STAT3 activation and chronic itch require IP3R1/TRPC-dependent Ca2+ signals in mice
Shiratori‐Hayashi, M., Chiharu, Y., Eguchi, K., Shiraishi, Y., Kohno, K., Mikoshiba, K., Inoue, K., Nishida, M., & Tsuda, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.06.039 · Cited by 65
Robustness and Information Transfer within IL-6-induced JAK/STAT Signalling
Billing, U., Jetka, T., Nortmann, L., Wundrack, N., Komorowski, M., Waldherr, S., Schaper, F., & Dittrich, A. (2019) · Communications Biology · doi:10.1038/s42003-018-0259-4 · Cited by 64
Lolansen, S. D., Rostgaard, N., Oernbo, E. K., Juhler, M., Simonsen, A. H., & MacAulay, N. (2021) · Disease Markers · doi:10.1155/2021/8834822 · Cited by 61
Maes, M. H. J., Sirivichayakul, S., Matsumoto, A. K., Maes, A., Michelin, A. P., Semeão, L. D. O., Pedrão, J. V. D. L., Moreira, E. G., Barbosa, D. S., Geffard, M., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01882-w · Cited by 56
König, C., Morch, E., Eitner, A., Möller, C., Turnquist, B. P., Schaible, H., & Ebersberger, A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4159-15.2016 · Cited by 43
Interleukin-6 in Traumatic Brain Injury: A Janus-Faced Player in Damage and Repair
Ciryam, P., Gerzanich, V., & Simard, J. M. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2023.0135 · Cited by 55
Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [ 18F ]‐ FEMPA PET Study
Khan, W., Corben, L. A., Bilal, H., Vivash, L. E., Delatycki, M. B., Egan, G. F., & Harding, I. H. (2021) · Movement Disorders · doi:10.1002/mds.28825 · Cited by 54
Zou, Z., Chen, J., Feng, H.-F., Cheng, Y., Wang, H., Zhou, Z., Guo, H., Zheng, W., & Xu, J. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239608 · Cited by 55
Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy
Cox, A., Sagot, Y., Hédou, G., Grek, C. L., Wilkes, T., Vinik, A. I., & Ghatnekar, G. S. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00089 · Cited by 53
Oliveira-Junior, M. S., Pereira, É. P. L., de Amorim, V. C. M., Reis, L. T. C., do Nascimento, R. P., da Silva, V. D. A., & Costa, S. L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.055 · Cited by 54
Expression pattern of perilipins in human brain during aging and in Alzheimer's disease
Conte, M., Medici, V., Malagoli, D., Chiariello, A., Cirrincione, A., Davin, A., Chikhladze, M., Vasuri, F., Legname, G., Ferrer, I., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12756 · Cited by 53
Grønhøj, M., Clausen, B., Fenger, C., Lambertsen, K., & Finsen, B. (2017) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2017.05.019 · Cited by 51
Dinicola, S., Proietti, S., Cucina, A., Bizzarri, M., & Fuso, A. (2017) · Antioxidants · doi:10.3390/antiox6040074 · Cited by 50
Bóbbo, V. C. D., Jara, C. P., Mendes, N. F., Morari, J., Velloso, L. A., & ARAUJO, E. P. D. (2019) · BioMed Research International · doi:10.1155/2019/1365210 · Cited by 53
Liu, L., Xu, D., Wang, T., Zhang, Y., Yang, X., Wang, X., & Tang, Y. (2019) · Pain · doi:10.1097/j.pain.0000000000001681 · Cited by 52
Transient microglial absence assists postmigratory cortical neurons in proper differentiation
Hattori, Y., Naito, Y., Tsugawa, Y., Nonaka, S., Wake, H., Nagasawa, T., Kawaguchi, A., & Miyata, T. (2020) · Nature Communications · doi:10.1038/s41467-020-15409-3 · Cited by 49
Ojo, O. A., Rotimi, D. E., Ojo, A. B., Ogunlakin, A. D., & Ajiboye, B. O. (2023) · Scientific Reports · doi:10.1038/s41598-023-28893-6 · Cited by 52
Shen, S., Liang, L., Shi, T., Shen, Z., Yin, S., Zhang, J., Li, W., Mi, W., Wang, Y., Zhang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202412556 · Cited by 57
Interleukin 6 and Aneurysmal Subarachnoid Hemorrhage. A Narrative Review
Simon, M., & Grote, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084133 · Cited by 49
Müller, S. A., Shmueli, M. D., Feng, X. M., Tüshaus, J., Schumacher, N., Clark, R., Smith, B. E., Chi, A., Rose‐John, S., Kennedy, M. E., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00596-6 · Cited by 51
Trindade, P., Loiola, E. C., Gasparotto, J., Ribeiro, C. T., Cardozo, P. L., Devalle, S., Salerno, J. A., Ornelas, I. M., Ledur, P. F., Ribeiro, F. M., et al. (2020) · Glia · doi:10.1002/glia.23786 · Cited by 47
Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
Pak, V. M., Onen, S. ‐., Bliwise, D. L., Kutner, N. G., Russell, K. L., & Onen, F. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00069 · Cited by 53
The role of exercise-induced peripheral factors in sleep regulation
Tan, X. W., van Egmond, L. T., Cedernaes, J., & Benedict, C. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101096 · Cited by 52
Neurobiology of coronaviruses: Potential relevance for COVID-19
Cataldi, M., Pignataro, G., & Taglialatela, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105007 · Cited by 51
White matter-associated microglia: New players in brain aging and neurodegenerative diseases
Ahn, K., Lee, S., & Mook‐Jung, I. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101574 · Cited by 50
Leo, A., Nesci, V., Tallarico, M., Amodio, N., Cantafio, E. M. G., Sarro, G. D., Constanti, A., Russo, E., & Citraro, R. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00893-8 · Cited by 47
Milligan, C., Atassi, N., Babu, S., Barohn, R. J., Caress, J. B., Cudkowicz, M., Evora, A., Hawkins, G. A., Wosiski‐Kuhn, M., Macklin, E. A., et al. (2021) · Muscle & Nerve · doi:10.1002/mus.27339 · Cited by 46
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
Gutiérrez, I. L., Russo, C. D., Novellino, F., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116143 · Cited by 53
Gynther, M., Puris, E., Peltokangas, S., Auriola, S. O. K., Kanninen, K. M., Koıstınaho, J., Huttunen, K. M., Ruponen, M., & Vellonen, K. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2546-7 · Cited by 48
Immunomodulatory effects of progesterone and selective ligands of membrane progesterone receptors
Polikarpova, A. V., Levina, I. S., Сигай, Н. В., Zavarzin, I. V., Morozov, I. A., Рубцов, П. М., Guseva, A. A., Smirnova, О. V., & Shchelkunova, T. A. (2019) · Steroids · doi:10.1016/j.steroids.2019.02.009 · Cited by 45
Post-traumatic Stress Disorder: Focus on Neuroinflammation
Li, J., Tong, L., Schock, B. C., & Ji, L.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03320-z · Cited by 47
Karababa, A., Groos-Sahr, K., Albrecht, U., Keitel, V., Shafigullina, A. K., Görg, B., & Häussinger, D. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2060-4 · Cited by 43
Tao, H., Chen, X., Zhou, H., Fu, J., Yu, Q., & Liu, Y. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01271 · Cited by 43
Imran, M., Shah, F. A., Nadeem, H., Zeb, A., Faheem, M., Naz, S., Bukhari, A., Ali, T., & Li, S. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00659 · Cited by 44
Santini, M., Haberle, S., Lepej, S. Ž., Savić, V., Kusulja, M., Papić, N., Višković, K., Župetić, I., Savini, G., Barbić, L., et al. (2022) · Pathogens · doi:10.3390/pathogens11010052 · Cited by 41
Hu, J., Zhang, Y., Chunxia, H., Feng, X., He, S., Zhang, Y., & Maze, M. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.08.019 · Cited by 42
The impact of drugs for multiple sclerosis on sleep
Lanza, G., Ferri, R., Bella, R., & Ferini‐Strambi, L. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516664034 · Cited by 42
Liu, Q., Chen, W., Fan, X., Wang, J., Fu, S., Cui, S., Liao, F., Cai, J., Wang, X., Huang, Y. H., et al. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.03.005 · Cited by 42
Metadata
- Authors
- Rothaug, M., Becker-Pauly, C., & Rose-John, S.
- Affiliations
- Christian-Albrechts-Universität zu Kiel (DE)
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 1863
- Issue
- 6
- Pages
- 1218-1227
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2308447553
- Cited by
- 491
- References
- 170
- Citations by year
- 2026: 30 · 2025: 51 · 2024: 44 · 2023: 54 · 2022: 89 · 2021: 74 · 2020: 59 · 2019: 37 · 2018: 22 · 2017: 23 · 2016: 8
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 654)
- Proteolysis as a Regulatory Event in Pathophysiology (SFB 877)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- interleukin-6, IL-6 signaling, neuroinflammation, multiple sclerosis, Parkinson's disease, Alzheimer's disease, sleep, REM sleep, oligodendrocyte differentiation, peripheral nerve regeneration, neurotrophic factors, soluble IL-6 receptor, gp130, trans-signaling, sgp130Fc, neurodegeneration, microglia
- MeSH terms
- Animals, Central Nervous System, Humans, Models, Biological, Protein Binding, Signal Transduction, Interleukin-6, Neurodegenerative Diseases, Receptors, Interleukin-6, Cytokine Receptor gp130
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review